Castle Biosciences Inc — Balance Sheet (NASDAQ:CSTL) | MetaTrader

Open full chart

Financials

Overview Statement Statistics Dividends

Quarterly Annual

Total assets 439.33 M462.57 M447.33 M453.34 M531.24 M578.56 M Total liabilities 23.64 M50.83 M48.18 M62.07 M75.4 M107.68 M Total equity 415.69 M411.74 M399.15 M391.27 M455.83 M470.87 M Total liabilities & shareholders' equities 439.33 M462.57 M447.33 M453.34 M531.24 M578.56 M Total debt —————— Net debt ——————

Noticias

RCKT's Q4 Loss Narrower Than Estimated, Pipeline in Focus

PBYI Q4 Earnings & Sales Beat Estimates, Stock Down on Weak 2026 View

TGTX Q4 Earnings Lag Estimates, Briumvi Sales Drive Top Line

PRGO Q4 Earnings Miss, Sales Beat, Stock Down on Weak 2026 View

Intellia Rises on Q4 Earnings & Revenue Beat, Focuses on Pipeline

Pacira BioSciences Q4 Earnings and Revenues Miss Estimates, Stock Down

Kymera Q4 Loss Wider Than Expected, Cash Boost Extends Runway

Castle Biosciences, Inc. (CSTL) Q4 2025 Earnings Call Transcript

Castle Biosciences, Inc. (CSTL) Reports Q4 Loss, Beats Revenue Estimates

Castle Biosciences T4 2025: volúmenes de pruebas suben 42%, entra al mercado de DA

Castle Biosciences T4 2025: volumen de pruebas sube 42%, entra a mercado AD

Castle Biosciences Q4 2025 slides: test volumes surge 42%, enters AD market